Gilead Sciences, Inc. (GILD)
148.43
-1.40
(-0.93%)
USD |
NASDAQ |
Feb 24, 11:03
Gilead Sciences SG&A Expense (Quarterly) : 1.794B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.952B |
| Johnson & Johnson | 6.753B |
| Eli Lilly & Co. | 3.132B |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Moderna, Inc. | 308.00M |